help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 14, 2004
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1863
A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/3/1371    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Kugu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Kugu, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEUPROLIDE

Submitted on September 21, 2004
Accepted on November 23, 2004

Results of Long-Term Follow-Up After Treatment of Central Precocious Puberty with Leuprorelin Acetate: Evaluation of Effectiveness of Treatment and Recovery of Gonadal Function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty

Toshiaki Tanaka*, Hiroo Niimi, Nobutake Matsuo, Kenji Fujieda, Katsuhiko Tachibana, Kenji Ohyama, Mari Satoh, and Koji Kugu

Department of Endocrinology and Metabolism, National Center for Child Health and Development (T.T., N.M.), Tokyo 157-8535; Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba (H.N.), Chiba 260-8670; Department of Pediatrics, Asahikawa Medical College (K.F.), Asahikawa 078-8510; Division of Endocrinology and Metabolism, Kanagawa Children's Medical Center (K.T.), Yokohama 232-8555; Department of Clinical Nursing and Pediatrics, Faculty of Medicine, University of Yamanashi (K.O.), Yamanashi 409-3898; Department of Pediatrics, School of Medicine, Toho University (M.S.), Tokyo 143-8540; Department of Obstetrics and Gynecology, Graduate School of Medicine, University of Tokyo (K.K.), Tokyo 113-0033, Japan

* To whom correspondence should be addressed. E-mail: tanaka-t{at}ncchd.go.jp.

We evaluated the effect of leuprorelin treatment on adult height (AH) and followed recovery of reproductive function in 63 girls and 13 boys with central precocious puberty (CPP). Mean treatment durations were 3.8 ± 2.0 and 4.1 ± 2.5 yr, and post-treatment follow-up durations 3.5 ± 1.3 and 2.6 ± 1.1 yr for girls and boys, respectively. AH was 154.5 ± 5.7 cm for girls, and 89.5% of girls reached AH within their target height (TH) range. For boys, AH was 163.2 ± 13.0 cm and 90.9% reached TH range. It appeared that the Bayley-Pinneau method modified for Japanese children using a table for advanced bone age (BA) overestimated AH in CPP, and this method using a table for average BA and projected height for BA were suitable for prediction of AH in CPP.

Menarche or re-menarche occurred in 96.8% of girls at the age of 13.1 ± 1.5 yr. Of 11 girls who contributed urine samples, all 7 idiopathic and 2 organic cases were considered to have ovulation. Serum testosterone levels reached normal adult level in all boys.

In conclusion, long-term leuprorelin treatment for children with CPP improved AH and had no adverse effects on recovery of reproductive function.


Key words: central precocious puberty • GnRH analog • adult height • reproductive function




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. M. Pasquino, I. Pucarelli, F. Accardo, V. Demiraj, M. Segni, and R. Di Nardo
Long-Term Observation of 87 Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogs: Impact on Adult Height, Body Mass Index, Bone Mineral Content, and Reproductive Function
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 190 - 195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society